Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001493152-21-026271
Filing Date
2021-10-26
Accepted
2021-10-25 18:16:31
Documents
18

Document Format Files

Seq Description Document Type Size
1 formf-1.htm F-1 4114671
2 ex23-1.htm EX-23.1 3320
3 drsa_1.jpg GRAPHIC 55053
4 drsa_3.jpg GRAPHIC 165209
5 drsa_4.jpg GRAPHIC 270499
6 drsa_5.jpg GRAPHIC 394345
7 drsa_7.jpg GRAPHIC 290210
8 drsa_8.jpg GRAPHIC 380879
9 drsa_9.jpg GRAPHIC 220119
10 drsa_10.jpg GRAPHIC 202118
11 drsa_11.jpg GRAPHIC 417876
12 drsa_12.jpg GRAPHIC 225869
13 drsa_13.jpg GRAPHIC 594923
14 image_002.jpg GRAPHIC 258841
15 image_003.jpg GRAPHIC 451338
16 image_004.jpg GRAPHIC 466674
17 image_006.jpg GRAPHIC 260063
18 backcover_001.jpg GRAPHIC 7598
  Complete submission text file 0001493152-21-026271.txt   10538208
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) Ltd (Filer) CIK: 0001872812 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-260492 | Film No.: 211345225
SIC: 2836 Biological Products, (No Diagnostic Substances)